[CBAY] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -4,093.32%
YoY- -22.55%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -33,882 -24,505 -22,682 -11,421 -26,282 -18,563 -8,234 26.57%
Tax -215 3,142 29 -816 1,425 1,453 -1,540 -27.96%
NP -33,882 -27,647 -22,682 -11,421 -26,282 -18,563 -8,234 26.57%
Tax Rate - - - - - - - -
Total Cost 33,882 27,647 22,682 11,421 26,282 18,563 8,234 26.57%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.32 -0.33 -0.33 -0.17 -0.38 -0.31 -0.21 7.26%
EPS Diluted -0.32 -0.31 -0.33 -0.17 -0.38 -0.31 -0.21 7.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.